STRATA Skin Sciences, Inc. (SSKN)
Largest Insider Buys in Sector
SSKN Stock Price History Chart
SSKN Stock Performance
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Insider Activity of STRATA Skin Sciences, Inc.
Over the last 12 months, insiders at STRATA Skin Sciences, Inc. have bought $1.07M and sold $320 worth of STRATA Skin Sciences, Inc. stock.
On average, over the past 5 years, insiders at STRATA Skin Sciences, Inc. have bought $439,611 and sold $320 worth of stock each year.
Highest buying activity among insiders over the last 12 months: 22NW, LP (10 percent owner) — $1.02M. Moccia Robert Joseph (Chief Executive Officer) — $28,308. Lesovitz Christopher (Chief Financial Officer) — $10,153.
The last purchase of 20,000 shares for transaction amount of $8,956 was made by Gov Shmuel (COO) on 2023‑12‑01.
List of Insider Buy and Sell Transactions, STRATA Skin Sciences, Inc.
| 2023-12-01 | Gov Shmuel | COO | 20,000 0.0586% | $0.45 | $8,956 | +15.95% | ||
| 2023-11-16 | Sale | Rubinstein Samuel | director | 1,000 0.0021% | $0.32 | $320 | +11.04% | |
| 2023-08-16 | 22NW, LP | 10 percent owner | 1.85M 5.0569% | $0.55 | $1.02M | -10.34% | ||
| 2023-08-10 | Moccia Robert Joseph | Chief Executive Officer | 42,000 0.1268% | $0.67 | $28,308 | -18.75% | ||
| 2023-08-10 | Lesovitz Christopher | Chief Financial Officer | 15,151 0.0455% | $0.67 | $10,153 | -18.75% | ||
| 2022-06-15 | Rubinstein Samuel | 1,050 0.0031% | $1.04 | $1,092 | -2.97% | |||
| 2022-05-12 | Lesovitz Christopher | Chief Financial Officer | 23,131 0.0691% | $1.12 | $25,907 | -7.96% | ||
| 2022-03-25 | Humphries William D. | 16,950 0.0523% | $1.73 | $29,385 | -38.40% | |||
| 2022-03-24 | Moccia Robert Joseph | Chief Executive Officer | 33,300 0.0962% | $1.57 | $52,398 | -36.37% | ||
| 2022-03-24 | Humphries William D. | 14,783 0.043% | $1.58 | $23,387 | -36.37% | |||
| 2021-09-08 | SHAMIR NACHUM | director | 44,808 0.1677% | $1.47 | $65,951 | -5.96% | ||
| 2021-09-07 | SHAMIR NACHUM | director | 26,612 0.0995% | $1.42 | $37,726 | -2.41% | ||
| 2019-11-21 | Via LuAnn | director | 5,000 0.0158% | $2.50 | $12,500 | -44.13% | ||
| 2018-06-14 | HILL MATTHEW C | CFO | 10,000 0.0431% | $1.96 | $19,618 | +42.05% | ||
| 2018-06-14 | Via LuAnn | director | 5,000 0.0214% | $1.95 | $9,750 | +42.05% | ||
| 2018-06-08 | Via LuAnn | director | 30,000 0.1314% | $2.12 | $63,500 | +34.06% | ||
| 2018-06-05 | NAVARRO SAMUEL E | director | 20,000 0.0855% | $2.01 | $40,122 | +37.81% | ||
| 2018-05-21 | COYNE JAMES L | director | 3,000 0.0128% | $1.68 | $5,040 | +63.91% | ||
| 2016-11-28 | MCCANEY FRANK J | President & CEO | 20,000 0.1966% | $0.51 | $10,106 | -3.85% | ||
| 2016-03-11 | Sale | Broadfin Healthcare Master Fund Ltd | 10 percent owner | 216,000 4.6492% | $1.26 | $272,800 | -41.90% |
Insider Historical Profitability
| 22NW, LP | 10 percent owner | 5369954 15.3214% | $3.13 | 1 | 0 | |
| Moccia Robert Joseph | Chief Executive Officer | 235300 0.6713% | $3.13 | 2 | 0 | |
| Rubinstein Samuel | director | 177602 0.5067% | $3.13 | 1 | 1 | |
| Lesovitz Christopher | Chief Financial Officer | 38282 0.1092% | $3.13 | 2 | 0 | |
| Gov Shmuel | COO | 20000 0.0571% | $3.13 | 1 | 0 | |
| BONANZA CAPITAL LTD | 10 percent owner | 1524787 4.3505% | $3.13 | 1 | 11 | |
| Broadfin Healthcare Master Fund Ltd | 10 percent owner | 1008297 2.8768% | $3.13 | 0 | 2 | |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10 percent owner | 761726 2.1733% | $3.13 | 0 | 12 | |
| Humphries William D. | 484440 1.3822% | $3.13 | 2 | 0 | ||
| Lufkin Dan W | 467115 1.3328% | $3.13 | 15 | 0 | ||
| Gulfo Joseph V | Chairman, CEO & President | 208311 0.5943% | $3.13 | 14 | 0 | |
| SHAMIR NACHUM | director | 207792 0.5929% | $3.13 | 2 | 0 | |
| Coradini Robert | Chairman | 139024 0.3967% | $3.13 | 5 | 0 | |
| Castleman Breaux | director | 107238 0.306% | $3.13 | 7 | 0 | |
| DIMUN ANTHONY J | director | 101013 0.2882% | $3.13 | 2 | 0 | |
| Bronner William R | Vice-President, Legal Counsel | 75885 0.2165% | $3.13 | 1 | 0 | |
| Crane Rosemary A | CEO and President | 67570 0.1928% | $3.13 | 1 | 0 | |
| Chryssis George C | director | 41000 0.117% | $3.13 | 11 | 0 | |
| Cleary Martin D | director | 40443 0.1154% | $3.13 | 10 | 0 | |
| Via LuAnn | director | 35570 0.1015% | $3.13 | 5 | 0 | +10.66% |
| Swintek Kathryn B | director | 33513 0.0956% | $3.13 | 3 | 0 | |
| STONE DAVID K | director | 23514 0.0671% | $3.13 | 2 | 0 | |
| Wagner Gerald D | Acting Chief Operating Officer | 20700 0.0591% | $3.13 | 3 | 0 | |
| MCCANEY FRANK J | President & CEO | 20000 0.0571% | $3.13 | 1 | 0 | <0.0001% |
| NAVARRO SAMUEL E | director | 20000 0.0571% | $3.13 | 1 | 0 | +37.81% |
| Egger Anne M | director | 16350 0.0466% | $3.13 | 5 | 0 | |
| ODONNELL JEFFREY F | director | 13513 0.0386% | $3.13 | 1 | 0 | |
| Cook Robert W. | Chief Financial Officer | 10000 0.0285% | $3.13 | 1 | 0 | +0.83% |
| HILL MATTHEW C | CFO | 10000 0.0285% | $3.13 | 1 | 0 | +42.05% |
| Goddard John Geoffrey | director | 10000 0.0285% | $3.13 | 1 | 0 | |
| Cheng-Avery Tina | V.P. of Commercialization | 8000 0.0228% | $3.13 | 1 | 0 | |
| MEADS MINDY C | director | 5070 0.0145% | $3.13 | 1 | 0 | |
| Steinhart Richard I | Chief Financial Officer | 4000 0.0114% | $3.13 | 2 | 0 | |
| COYNE JAMES L | director | 3000 0.0086% | $3.13 | 1 | 0 | +63.91% |
Institutional Investor Ownership
| 22Nw Fund Lp | $2.03M | 15.32 | 5.37M | 0% | +$0 | 2.02 | |
| Nantahala Capital Management Llc | $1.17M | 8.81 | 3.09M | -1.23% | -$14,481.55 | 0.12 | |
| Renaissance Technologies | $402,000.00 | 3.03 | 1.06M | -0.43% | -$1,739.85 | <0.01 | |
| The Vanguard Group | $324,400.00 | 2.45 | 858,202 | 0% | +$0 | <0.0001 | |
| One Seven (We Are One Seven, LLC) | $64,797.00 | 0.49 | 171,420 | +140.02% | +$37,800.14 | <0.01 | |
| Geode Capital Management | $45,830.00 | 0.35 | 121,200 | +9.56% | +$4,000.29 | <0.0001 | |
| Creative Planning | $37,860.00 | 0.29 | 100,160 | 0% | +$0 | <0.0001 | |
| Perritt Capital Management Inc | $37,800.00 | 0.29 | 100,000 | 0% | +$0 | 0.01 | |
| BlackRock | $36,416.00 | 0.28 | 96,340 | -1.13% | -$414.28 | <0.0001 | |
| Northern Trust | $10,270.00 | 0.08 | 27,170 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $9,778.00 | 0.07 | 25,867 | -60.83% | -$15,181.66 | <0.0001 | |
| UBS | $6,193.00 | 0.05 | 16,384 | New | +$6,193.00 | <0.0001 | |
| Tower Research Capital | $4,516.00 | 0.03 | 11,948 | +10.65% | +$434.67 | <0.0001 | |
| State Street | $4,328.00 | 0.03 | 11,450 | 0% | +$0 | <0.0001 | |
| Carmichael Hill & Associates | $1,134.00 | 0.01 | 3,000 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $208.00 | <0.01 | 551 | -13.09% | -$31.33 | <0.0001 | |
| Morgan Stanley | $193.00 | <0.01 | 510 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 229 | -28.44% | -$0 | <0.0001 | |
| Wells Fargo | $64.00 | <0.01 | 170 | +1.8% | +$1.13 | <0.0001 | |
| Allworth Financial Lp | $21.00 | <0.01 | 53 | 0% | +$0 | <0.0001 | |
| Group One Trading | $0 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Fidelity Investments | $17.00 | <0.01 | 45 | New | +$17.00 | <0.0001 |